HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jai-Jen Tsai Selected Research

amentoflavone

5/2022Inactivation of AKT/ERK Signaling and Induction of Apoptosis Are Associated With Amentoflavone Sensitization of Hepatocellular Carcinoma to Lenvatinib.
5/2018Amentoflavone Inhibits ERK-modulated Tumor Progression in Hepatocellular Carcinoma In Vitro.
1/2018Amentoflavone Enhances the Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo.
1/2017Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jai-Jen Tsai Research Topics

Disease

9Hepatocellular Carcinoma (Hepatoma)
05/2022 - 02/2017
6Neoplasms (Cancer)
08/2020 - 01/2018
4Hemorrhage
10/2009 - 09/2008
3Osteosarcoma (Osteogenic Sarcoma)
03/2021 - 01/2017
3Neoplasm Metastasis (Metastasis)
03/2021 - 01/2017
2Body Weight (Weight, Body)
01/2018 - 01/2018
1Chronic Hepatitis C
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
08/2020
1Breast Neoplasms (Breast Cancer)
05/2018
1Intestinal Failure
11/2015
1Liver Diseases (Liver Disease)
06/2013
1Chronic Hepatitis (Chronic Active Hepatitis)
06/2013
1Stomach Volvulus
09/2010
1Hookworm Infections (Hookworm Infection)
10/2009
1Peptic Ulcer (Peptic Ulcers)
03/2009
1Critical Illness (Critically Ill)
11/2008
1Ulcer
11/2008

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
03/2021 - 01/2017
4amentoflavoneIBA
05/2022 - 01/2017
3Glycyrrhizic Acid (Glycyrrhizin)IBA
01/2022 - 06/2013
3regorafenibIBA
08/2020 - 02/2017
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2020 - 01/2018
2Phosphotransferases (Kinase)IBA
03/2021 - 08/2020
2Apoptosis Regulatory ProteinsIBA
03/2021 - 01/2018
2Sorafenib (BAY 43-9006)FDA Link
03/2021 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
08/2020 - 01/2020
22- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
01/2020 - 05/2018
2thiazolyl blueIBA
05/2018 - 01/2017
2Proton Pump InhibitorsIBA
03/2009 - 11/2008
2Pantoprazole (Protonix)FDA LinkGeneric
11/2008 - 09/2008
1lenvatinibIBA
05/2022
1Transcription Factors (Transcription Factor)IBA
08/2020
1Epidermal Growth Factor (EGF)IBA
08/2020
1Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2020
1magnololIBA
02/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2020
1Metalloproteases (Metalloproteinases)IBA
02/2020
1X-Linked Inhibitor of Apoptosis ProteinIBA
02/2020
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2020
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
01/2020
1LuciferasesIBA
01/2018
1NitrogenIBA
11/2015
1Capsules (Microcapsules)IBA
10/2009
1Omeprazole (Prilosec)FDA LinkGeneric
03/2009
1Epinephrine (Adrenaline)FDA LinkGeneric
03/2009
1Rabeprazole (Aciphex)FDA Link
03/2009
1Cimetidine (Biomet)FDA LinkGeneric
11/2008

Therapy/Procedure

2Total Parenteral Nutrition
11/2015 - 06/2013
1Aftercare (After-Treatment)
02/2020
1Intraperitoneal Injections
01/2020
1Intravenous Infusions
06/2013
1Conservative Treatment
09/2010
1Therapeutics
11/2008